The Children's Heart Program at the University of Maryland Medical Center is leading a first-of-its-kind clinical trial that will use stem cells to treat hypoplastic left heart syndrome (HLHS), a congenital heart disease. HLHS leaves the left ventricle underdeveloped, and this procedure strengthens the function of the right side of the patient's heart.
Led by Sunjay Kaushal, MD, PhD, the HLHS Clinical Trial tests the effectiveness of allogeneic mesenchymal stem cells in conjunction with the second palliative surgery, the Glenn (bidirectional cavopulmonary anastomosis) operation. These cells have been shown to remarkably improve cardiac function in adult hearts but have never been tested on the pediatric population until now.
After performing rigorous studies, the Food and Drug Administration (FDA) granted approval for this trial.
In this Phase I trial, 30 HLHS patients will be enrolled at the time of the second palliative operation. The first 10 patients will receive the stem cells, and their results will be used to determine feasibility and safety.
After enrollment for the initial group is completed, the following 20 participants will be enrolled on a 1:1 basis, with 10 receiving the stem cell treatment and the other 10 being viewed as a control group (not receiving the stem cells).
The HLHS Clinical Trial will assess two major endpoints:
Treatment with allogeneic mesenchymal stem cells aims to strengthen the right ventricle, improving the function of the heart and thus the patient's quality of life. If the treatment is effective, this ground-breaking procedure could be applied to other complicated congenital heart diseases, such as dilated cardiomyopathy.
Stem cells are unspecialized cells that can regenerate through cell division and have the potential to develop into many different cell types under certain conditions, including those with a more specialized function such as cardiac muscle cells.
This trial uses allogeneic mesenchymal stem cells, which are from donated human bone marrow cells. These particular cells have the remarkable capability to escape immune response, are readily accessible, safe to use and proven to be effective in adult patients with heart conditions.
In this trial, the stem cells will be injected in the right ventricle during the second palliative surgery for HLHS patients. If effective, the cells will act as a biological factory, secreting proteins that will make the right side of the heart stronger.
To view eligibility requirements, visit the HLHS Clinical Trials page.
Call 410-328-3778 for participation information.
Philanthropy allows us to advance cutting-edge research, teaching and patient care. To make a gift in support of this groundbreaking research, please visit the University of Maryland Medical System Foundation secure online giving page and select Pediatric Cardiovascular Research Fund in the dropdown menu.
Read the original:
Stem Cell Clinical Trial | University of Maryland Children ...
- Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement - Business Wire - October 13th, 2022
- Johns Hopkins Scientists Have Developed a Nanobody That May Treat Parkinson's Disease - SciTechDaily - September 25th, 2022
- UMD students contribute to tech, health fields with summer research projects - The Diamondback - September 16th, 2022
- Pair of Hopkins teams receive $200K in technology grants - Maryland Daily Record - August 22nd, 2022
- RoosterBio and AGC Biologics team up to accelerate manufacture of cell and exosome therapies - BioPharma-Reporter.com - August 22nd, 2022
- Stem Cell Transplant Reverses Sickle Cell Disease in Adults - July 3rd, 2022
- LONGEVERON INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - Marketscreener.com - May 15th, 2022
- Top Ways To Rejuvenate Your Body And Improve Your Well-being - The Southern Maryland Chronicle - April 19th, 2022
- BioCardia Announces FDA Approval of Its IND for NK1R+ Mesenchymal Stem Cells for the Treatment of Patients Recovering from Acute Respiratory Distress... - April 19th, 2022
- Synthetic biology's past, present and future explored in timely new account - Winnipeg Free Press - April 6th, 2022
- US is Out of Step on Primate Research With Rest of World - NewsClick - October 5th, 2021
- A Look Inside A Termite's Gut Wins The 11th Annual Nikon Small World in Motion Competition - PRNewswire - August 18th, 2021
- What really happened in Wuhan? - The Sunday Guardian Live - The Sunday Guardian - June 6th, 2021
- UMD Researchers Perform Crucial Proof-of-Concept ... - December 20th, 2020
- US gets more help in raging battle against COVID-19 as FDA authorizes Moderna vaccine, the second allowed for emergency use - USA TODAY - December 20th, 2020
- Sirnaomics to Initiate Phase I Study of STP705 in Treatment of Primary and Metastatic Liver Cancer | DNA RNA and Cells | News Channels -... - December 7th, 2020
- Trump was one of the first 10 patients to get an experimental COVID-19 treatment under special use - Yahoo News - October 8th, 2020
- New toilet, a VR camera and science experiments are heading to t - KAKE - October 8th, 2020
- ShoreRivers awarded DNR grant for two restoration projects - MyEasternShoreMD - August 26th, 2020
- CRISPR cows could boost sustainable meat production, but regulations and wary consumers stand in the way - Genetic Literacy Project - August 26th, 2020
- Over $8M in 2020 Stem Cell Funding Awards Continue to Fuel Marylands Leading Cell Therapy Industry - BioBuzz - June 24th, 2020
- Researchers develop nanoengineered bioink to 3D print functional bone tissue - 3D Printing Industry - May 27th, 2020
- 'Virus Goes In, Virus Goes Out': Advocates Call For Release Of More Low-Level Prisoners To Stem Infection Rate - Kaiser Health News - May 22nd, 2020
- What Do New Neurons in the Brains of Adults Actually Do? - The Scientist - May 7th, 2020
- David C. Karli is Offering a New Ray of Hope Through Regenerative Medicine - RESPECT. - May 3rd, 2020
- Could Innate Immunology Save Us From the Coronavirus? - The New York Times - May 3rd, 2020
- Watch: Hogan orders closure of bars, restaurants, theaters and gyms, restricts gatherings - Maryland Daily Record - March 22nd, 2020
- Dr Borehams Crucible: The small cap biotechs trying to make a buck from coronavirus - Stockhead - March 9th, 2020
- The Aussie Biotech Companies Trying To Make A Buck From Coronavirus - D'Marge - March 9th, 2020
- Organoids, iPSCs, and advanced cell models: Advancing discovery from basic research to drug discovery - Science Magazine - March 4th, 2020
- Maryland Stem Cell Center Consortium & Core Facility ... - March 4th, 2020
- Serving those who serve - The Hub at Johns Hopkins - November 14th, 2019
- BioLineRx Presents Preclinical Data From Triple Combination of BL-8040, Anti PD-1 and Chemotherapy Demonstrating Significant Reduction in Pancreatic... - November 6th, 2019
- VetStem Biopharma Shares the Success Story of Ole who was Treated with VetStem Cell Therapy by Dr. Holly Mullen - PR Web - November 6th, 2019
- Contrasting of Applied Therapeutics Inc. (APLT) and Neuralstem Inc. (NASDAQ:CUR) - MS Wkly - November 6th, 2019
- Reviewing Synthetic Biologics Inc. (SYN)'s and Asterias Biotherapeutics Inc. (:)'s results - FinanceMercury - November 6th, 2019
- Comparing of Neuralstem Inc. (CUR) and Allakos Inc. (NASDAQ:ALLK) - MS Wkly - November 6th, 2019
- Head-To-Head Survey: Intrexon (NASDAQ:XON) versus US Stem Cell (NASDAQ:USRM) - Riverton Roll - September 25th, 2019
- Analyzing US Stem Cell (OTCMKTS:USRM) and Intrexon (OTCMKTS:XON) - TechNewsObserver - September 25th, 2019
- Reviewing Intrexon (NASDAQ:XON) & US Stem Cell (NASDAQ:USRM) - Mayfield Recorder - September 25th, 2019
- Artificially Engineering Intestine - Mirage News - September 25th, 2019
- Prothena Corporation plc (PRTA)'s Financial Results Comparing With Neuralstem Inc. (NASDAQ:CUR) - The EN Herald - September 25th, 2019
- cord_blood - Maryland - September 14th, 2019
- Stem Cells and Type 1 Diabetes: What the Future Has in ... - April 24th, 2019
- Stem Cell Therapy in Maryland | Stem Cell Professionals - April 5th, 2019
- Meristem - Wikipedia - January 17th, 2019
- Stem Cell Therapy in Annapolis Maryland | Stem Cell ... - October 25th, 2018
- Stem Cell Centers - Towson > Stem Cell Centers - October 6th, 2018
- STEM CELL THERAPY - Orthopedic and Wellness Maryland - September 5th, 2018
- Patient Resources | University of Maryland School of Medicine - September 5th, 2018
- Baltimore, Maryland Stem Cell Transplants, Montgomery ... - August 17th, 2018
- Nervous System Stem Cells Can Replace Themselves, Give ... - July 3rd, 2018
- Excellence in Stem Cell Research | University of Maryland ... - June 24th, 2018
- Maryland Stem Cell Research Fund: 2014 Awardees - June 24th, 2018
- Catholic response to stem cells - Featured Today ... - October 14th, 2017
- Free stem cell Essays and Papers - 123HelpMe - October 12th, 2017
- How Stem Cell Therapy Can Help Repair and Regenerate Your Body - October 12th, 2017
- How Stem Cell Therapy Can Help Repair and ... - Mercola.com - September 4th, 2017
- Science and technology to get boost from CRS-12 mission - SpaceFlight Insider - August 12th, 2017
- Cannon Scholars visit National Institute of Standards and Technology - Dover Post - August 9th, 2017
- Lab-Grown, Virus-Free Stem Cells Repair Retinal Tissue in ... - August 9th, 2017
- Roanoke researchers pursue treatments for the type of deadly brain cancer affecting McCain - Roanoke Times - August 3rd, 2017
- The Maryland Stem Cell Research Fund (MSCRF) | Tedco - November 25th, 2016
- Center for Stem Cell Biology & Regenerative Medicine ... - November 14th, 2016
- Ginger | University of Maryland Medical Center - September 6th, 2016
- Johns Hopkins Team Creates Stem Cells From Schizophrenia ... - September 5th, 2016
- Human Induced Pluripotent Stem Cell Derived Neuronal Cells ... - August 18th, 2016
- Maryland Stem Cell Center Consortium and Core Facility ... - August 12th, 2016
- Human Stem Cells Institute - Wikipedia, the free encyclopedia - October 19th, 2015
- Patients' Own Genetically Altered Immune Cells Show ... - October 19th, 2015
- Maryland Stem Cell Research Fund: Funding Opportunities - July 2nd, 2015
- MRI based on a sugar molecule can tell cancerous from noncancerous cells - March 27th, 2015
- MD Stem Cells Release Optic Nerve Vision Loss Reversed ... - March 22nd, 2015
- TiGenix: TiGenix reports its full year 2014 results - March 18th, 2015
- Gene regulatory path revealed as target for therapy of aggressive pediatric brain cancer - March 10th, 2015
- American Spine offers experimental fix for pain -- Gazette.Net - January 28th, 2015
- American Spine offers experimental fix for pain - January 28th, 2015
- Toughest Breast Cancer May Have Met Its Match - December 9th, 2014
- Bid on Stem Cells and Alcohol-induced Tissue Injuries (R21 ... - November 12th, 2014
- Head, National Institutes of Health Stem Cell Technology ... - November 11th, 2014